Adjuvant works with small-mid cap biotech and device companies to find development partners for their lead and secondary programs. We work rapidly to develop positioning strategies for the programs and to qualify potential targets. Based on our global pharma and large cap biotech network we can present opportunities to key decision makers much faster than most of our competitors. We also can help our clients consider alternative sources of financing, including from the federal government, for some earlier stage programs to position them for more lucrative partnerships downstream. Our team also possesses deep regulatory knowledge in a number of product areas and we assist our clients in presenting a clear and concise regulatory outlook as we explore partnering opportunities. Finally, we also work with platform and drug discovery companies to find partners and clients for their drug discovery services.